Amanda Weissman
Dermatology · Oklahoma City, OKNPI 1710553987
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,376 of the $8,072 with a category attached, or 79.0%. 23 manufacturers reported payments, led by AbbVie at 27.4% of the total. Reporting peaked in 2023 at $3,660 and has fallen 50.7% since, to $1,805 in 2025.
Across 74 payments — averaging $109.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Lilly USA, LLC$848
- Boehringer Ingelheim$560
- Sanofi$476
- Arcutis Biotherapeutics, Inc.$419
- E.r. Squibb & Sons, L.L.C.$335
- plus $3K from 17 others
What the payments were for
- Travel & lodging$1,61220%
- Food & beverage$6,37679%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $2,208 |
| Lilly USA, LLC | 10 | $848 |
| Boehringer Ingelheim | 6 | $560 |
| Sanofi | 6 | $476 |
| Arcutis Biotherapeutics, Inc. | 4 | $419 |
| E.r. Squibb & Sons, L.L.C. | 3 | $335 |
| Organogenesis Inc. | 4 | $316 |
| Kyowa Kirin, Inc. | 3 | $314 |
| Johnson & Johnson | 2 | $280 |
| UCB, Inc. | 4 | $274 |
| Novartis | 3 | $262 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $245 |
| Galderma Laboratories, L.p. | 2 | $230 |
| Dermavant Sciences, Inc. | 2 | $226 |
| Janssen Scientific Affairs, LLC | 2 | $215 |
| Sun Pharmaceutical Industries Inc. | 2 | $203 |
| Incyte Corporation | 1 | $140 |
| Pfizer | 1 | $117 |
| Krystal Biotech Inc | 1 | $117 |
| Biofrontera Inc. | 1 | $101 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $98 |
| Amgen | 1 | $74 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,072 in reported general payments places this provider in the 70th percentile of 114 dermatology providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 27 | $1,362 |
| Ketoconazole | 55 | $1,090 |
| Fluorouracil | 12 | $884 |
| Clindamycin Phosphate | 14 | $319 |
| Spironolactone | 14 | $237 |
| Triamcinolone Acetonide | 15 | $235 |
| Hydrocortisone | 15 | $94 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Oklahoma City
- Yaohan LamOklahoma City$88K
- Kimberly JerdanOklahoma City$59K
- Mark DawkinsOklahoma City$56K
- Quy PhamOklahoma City$14K
- Sunita CrittendenOklahoma City$13K
- Tiffany BrazealOklahoma City$13K
- Robert LehrOklahoma City$11K
- Courtney CookOklahoma City$10K
- Clifford HendersonOklahoma City$9K
- Roy RindlerOklahoma City$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.